EUVIMEDOpdag EUVIMED
Crossref

Development of a quasi‐3D dosimeter using radiochromic plastic for patient‐specific quality assurance

Jin Dong Cho, Hyeongmin Jin, Seongmoon Jung, Jaeman Son, Chang Heon Choi, Jong Min Park, Jin Sung Kim, Jung-In Kim

Medical Physics · 2023

DOI: 10.1002/mp.16541 ↗

At a glance

Journal article in Medical Physics, 2023. Written by Jin Dong Cho and 7 co-authors. Institution: Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea. Major MEDLINE topics: Radiation Dosimeters, Radiotherapy, Intensity-Modulated. Cited 1 times so far (Crossref); 55 references. Funded by: National Research Foundation of Korea (NRF) funded by the Ministry of Education, Grant/Award Number, National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT, Grant/Award Number.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Patient‐specific QA verification ensures patient safety and treatment by verifying radiation delivery and dose calculations in treatment plans for errors. However, a two‐dimensional (2D) dose distribution is insufficient for detecting information on the three‐dimensional (3D) dose delivered to the patient. In addition, 3D radiochromic plastic dosimeters (RPDs) such as PRESAGE ® represent the volume effect in which the dosimeters have different sensitivities according to the size of the dosimeters. Therefore, to solve the volume effect, a Quasi‐3D dosimetry system was proposed to perform patient‐specific QA using predetermined‐sized and multiple RPDs.

Purpose

For patient‐specific quality assurance (QA) in radiation treatment, this study aims to assess a quasi‐3D dosimetry system using an RPD.

Methods

Gamma analysis was performed to verify the agreement between the measured and estimated dose distributions of intensity‐modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT). We fabricated cylindrical RPDs and a quasi‐3D dosimetry phantom. A practicability test for a pancreatic patient utilized a quasi‐3D dosimetry device, an in‐house RPD, and a quasi‐3D phantom. The dose distribution of the VMAT design dictated the placement of nine RPDs. Moreover, a 2D diode array detector was used for 2D gamma analysis (MapCHECK2). The patient‐specific QA was performed for IMRT, VMAT, and stereotactic ablative radiotherapy (SABR) in 20 prostate and head‐and‐neck patients. For each patient, six RPDs were positioned according to the dose distribution. VMAT SABR and IMRT/VMAT plans employed a 2%/2 mm gamma criterion, whereas IMRT/VMAT plans used a 3%/2 mm gamma criterion, a 10% threshold value, and a 90% passing rate tolerance. 3D gamma analysis was conducted using the 3D Slicer software.

Results

The average gamma passing rates with 2%/2 mm and 3%/3 mm criteria for relative dose distribution were 91.6% ± 1.4% and 99.4% ± 0.7% for the 3D gamma analysis using the quasi‐3D dosimetry system, respectively, and 97.5% and 99.3% for 2D gamma analysis using MapCHECK2, respectively. The 3D gamma analysis for patient‐specific QA of 20 patients showed passing rates of over 90% with 2%/2 mm, 3%/2 mm, and 3%/3 mm criteria.

Conclusions

The quasi‐3D dosimetry system was evaluated by performing patient‐specific QAs with RPDs and quasi‐3D phantom. The gamma indices for all RPDs showed more than 90% for 2%/2 mm, 3%/2 mm, and 3%/3 mm criteria. We verified the feasibility of a quasi‐3D dosimetry system by performing the conventional patient‐specific QA with the quasi‐3D dosimeters.

Subjects

MeSH terms (MEDLINE)

Radiation DosimetersRadiotherapy, Intensity-ModulatedMaleHumansRadiotherapy Planning, Computer-AssistedRadiotherapy DosageRadiometryPhantoms, ImagingQuality Assurance, Health Care

Author keywords

patient-specific quality assurancesquasi-3D dosimetry systemradiochromic three-dimensional dosimetry

Authors and institutions

  • Department of Radiation Oncology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.

Funding

  • National Research Foundation of Korea (NRF) funded by the Ministry of Education, Grant/Award Number
  • National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT, Grant/Award Number

Cite

APA

Cho, J. D., Jin, H., Jung, S., Son, J., Choi, C. H., Park, J. M., Kim, J. S., & Kim, J. I. (2023). Development of a quasi‐3D dosimeter using radiochromic plastic for patient‐specific quality assurance. Medical Physics. https://doi.org/10.1002/mp.16541

Vancouver

Cho JD, Jin H, Jung S, Son J, Choi CH, Park JM, et al. Development of a quasi‐3D dosimeter using radiochromic plastic for patient‐specific quality assurance. Medical Physics. 2023. doi:10.1002/mp.16541

BibTeX
@article{Cho2023,
  author = {Cho, Jin Dong and Jin, Hyeongmin and Jung, Seongmoon and Son, Jaeman and Choi, Chang Heon and Park, Jong Min and Kim, Jin Sung and Kim, Jung-In},
  title = {Development of a quasi‐3D dosimeter using radiochromic plastic for patient‐specific quality assurance},
  journal = {Medical Physics},
  year = {2023},
  doi = {10.1002/mp.16541}
}
Start for free →